期刊文献+

布-加综合征的诊断治疗59例 被引量:4

Diagnosis and treatment of Budd-Chiari syndrome: An analysis of 59 cases
下载PDF
导出
摘要 目的:分析布-加综合征(Budd-Chiari syndrome,BCS)的临床特点,提供该综合征的诊断治疗经验.方法:对59例BCS患者进行临床症状、体征、实验室检查、影像学检查及治疗情况进行回顾性分析.结果:59例患者主要临床表现为双下肢水肿17例,占28.8%,腹胀15例,占25.4%,腹胀伴双下肢水肿7例,占11.9%,彩色多普勒血管超声和血管造影的诊断率可达100%.55例患者行介入治疗,出院转归治愈23例,好转30例,未愈2例.结论:BCS的临床表现繁杂,极易误诊误治,对高度怀疑本病者,应行彩超多普勒血管检查和静脉造影进行确诊,早期诊断及治疗对预后有重要的影响.介入手术是有效的治疗手段. AIM: To analyze the clinical characteristics of Budd-Chiari syndrome to improve clinical awareness and diagnosis of this disease. METHODS: The clinical data for 59 patients diagnosed with Budd-Chiari syndrome were reviewed retrospectively to analyze patients’ clinical symptoms, signs, laboratory examination, iconography examination and treatment. RESULTS: Main clinical manifestations included lower-limb edema (17/59, 28.8%), abdominal distention (15/59, 25.4%), and abdominal distention with lower limb edema (7/59, 11.9%). The rate of diagnosis of Budd-Chiari syndrome by color Doppler vascular ultrasound and angiography was nearly 100%. Of 55 patients undergoing interventional therapy, 23 were cured, 30 had improved condition, and 2 had no significant improvement. CONCLUSION: Clinical manifestations of Budd-Chiari syndrome are complicated, which often leads to misdiagnosis and mistreatment. For patients highly suspected of having this disease, color Doppler vascular examination and venography should be conducted for diagnosis. Early diagnosis and treatment are important for prognosis. Interventional therapy is an effective method for Budd-Chiari syndrome.
作者 谢月萍 杜凡
出处 《世界华人消化杂志》 CAS 北大核心 2013年第3期282-285,共4页 World Chinese Journal of Digestology
关键词 布-加综合征 彩色多普勒诊断 血管造影 介入治疗 Budd-Chiari syndrome Color Doppler vascular examination Venography Interventional operation
  • 相关文献

参考文献12

  • 1Oguz Uskudar,Meral Akdogan,Nurgul Sasmaz,Sevinc Yilmaz,Muharrem Tola,Burhan Sahin.Etiology and portal vein thrombosis in Budd-Chiari syndrome[J].World Journal of Gastroenterology,2008,14(18):2858-2862. 被引量:14
  • 2彭涛,刘玉兰.布-加综合征64例临床分析[J].中华消化杂志,2007,27(11):774-776. 被引量:4
  • 3Menon K V,Shah V,Kamath P S.The Budd-Chiari Syndrome[].The New England Journal of Medicine.2004
  • 4Cho HH,O’’Connell JP,Cooney MF.et al.Minimizing tolerance and withdrawal to prolonged pediatric sedation:case report and review of the literature[].Intensive Care Medicine.2007
  • 5Qiao T,Liu CJ,Liu C,et al.Interventional endovasculartreatment of Budd-Chiari syndrome withlong-termfollow-up[].Swiss Medical Weekly.2005
  • 6Bahar K,Karayalcin S,Kaya M,et al.Percutaneous transhepatic venoplasty:an at ternative treatment for Budd-Chiari syndrome[].Turk J Gast roenterol.2002
  • 7Ludwig J,Hashimoto E,McGill DB,van Heerden JA.Classification of hepatic venous outflow ob-struction:ambiguous terminology of the Budd-Chi-ari syndrome[].Mayo Clinic Proceedings.1990
  • 8Emre A,Kalayci G,Ozden I,Bilge O,Acarli K,Kaymako lu S,Rozanes I,Okten A,Tekant Y,Alp-er A,Ario ul O.Mesoatrial shunt in Budd-Chiari syndrome[].The American Journal of Surgery.2000
  • 9Darwish Murad S,Valla DC,de Groen PC,Zeitoun G,Hopmans JA,Haagsma EB,van Hoek B,Hansen BE,Rosendaal FR,Janssen HL.Determinants of survival and the effect of portosystemic shunting in patients with Budd-Chiari syndrome[].Hepatology.2004
  • 10Darwish Murad S,Plessier A,Hernandez-Guerra M,Fabris F,Eapen CE,Bahr MJ,Trebicka J,Morard I,Lasser L,Heller J,Hadengue A,Langlet P,Miranda H,Primignani M,Elias E,Leebeek FW,Rosendaal FR,Garcia-Pagan JC,Valla DC,Janssen HL.Etiol-ogy,management,and outcome of the Budd-Chiari syndrome[].Annals of Internal Medicine.2009

二级参考文献27

  • 1张小明,张学民,李伟,沈晨阳,汪忠镐.直视下布加综合征根治术13例体会[J].中华普通外科杂志,2004,19(9):537-539. 被引量:11
  • 2[1]Menon KV,Shah V,Kamath PS.The Budd-Chiari syndrome.N Engl J Med 2004; 350:578-585
  • 3[2]Janssen HL,Meinardi JR,Vleggaar FP,van Uum SH,Haagsma EB,van Der Meer FJ,van Hattum J,Chamuleau RA,Adang RP,Vandenbroucke JP,van Hoek B,Rosendaal FR.Factor V Leiden mutation,prothrombin gene mutation,and deficiencies in coagulation inhibitors associated with BuddChiari syndrome and portal vein thrombosis:results of a casecontrol study.Blood 2000; 96:2364-2368
  • 4[3]Denninger MH,Chait Y,Casadevall N,Hillaire S,Guillin MC,Bezeaud A,Erlinger S,Briere J,Valla D.Cause of portal or hepatic venous thrombosis in adults:the role of multiple concurrent factors.Hepatology 2000; 31:587-591
  • 5[4]Hirshberg B,Shouval D,Fibach E,Friedman G,Ben-Yehuda D.Flow cytometric analysis of autonomous growth of erythroid precursors in liquid culture detects occult polycythemia vera in the Budd-Chiari syndrome.J Hepato12000; 32:574-578
  • 6[5]Deltenre P,Denninger MH,HiUaire S,Guillin MC,Casadevall N,Briere J,Erlinger S,Valla DC.Factor V Leiden related Budd-Chiari syndrome.Gut 2001; 48:264-268
  • 7[6]Bismuth E,Hadengue A,Hammel P,Benhamou JP.Hepatic vein thrombosis in Behcet's disease.Hepatology 1990; 11:969-974
  • 8[7]Shrestha SM,Okuda K,Uchida T,Maharjan KG,Shrestha S,Joshi BL,Larsson S,Vaidya Y.Endemicity and clinical picture of liver disease due to obstruction of the hepatic portion of the inferior vena cava in Nepal.J Gastroenterol Hepatol 1996; 11:170-179
  • 9[8]Mohanty D,Shetty S,Ghosh K,Pawar A,Abraham P.Hereditary thrombophilia as a cause of Budd-Chiari syndrome:a study from Western India.Hepatology 2001; 34:666-670
  • 10[9]Okuda H,Yamagata H,Obata H,Iwata H,Sasaki R,Imai F,Okudaira M,Ohbu M,Okuda K.Epidemiological and clinical features of Budd-Chiari syndrome in Japan.J Hepatol 1995; 22:1-9

共引文献16

同被引文献45

  • 1李枫,王峰,纪东华,王凝芳,刘永晟,李城.布-加综合征的影像诊断及综合介入治疗[J].中国医学影像技术,2008,24(S1):192-194. 被引量:4
  • 2李震,丁鹏绪,汪忠镐.布加综合征的规范化治疗[J].中国血管外科杂志(电子版),2013,5(3):155-157. 被引量:11
  • 3Ludwig J, Hashimoto E, McGilI DB, van Heerden JA. Classification of hepatic venous outflow obstruction: ambiguous terminology of the Budd-Chiari syndrome. Mayo Clin Proc 1990; 65:51-55 [PMID: 2296212 DOI: 10.1016/ S0025-6196(12)62109-0].
  • 4Wang ZG, Zhang FJ, Yi MQ, Qiang LX. Evolu- tion of management for Budd-Chiari syndrome: a team's view from 2564 patients. ANZ J 5urg 2005; 75:55-63 [PMID: 15740519].
  • 5Janssen HL, Garcia-Pagan JC, Elias E, MenthaG, Hadengue A, Valla DC. Budd-Chiari syn- drome: a review by an expert panel. ] Hepatol 2003; 38:364-371 [PMID: 12586305 DOI: 10.1016/ S0168-8278 (02)00434-8].
  • 6Kurihara Y, Shishido T, Oku K, Takamatsu M, Ishiguro H, Suzuki A, Sekita T, Shinagawa T, Ishihara T, Nakashima R, Fujii T, Okano Y. Poly- myositis associated with autoimmune hepati- tis, primary biliary cirrhosis, and autoimmune thrombocytopenic purpura. Mod Rheumatol 2011; 21:325-329 [PMID: 21240621 DOI: 10.1007/ s10165-010-0397-0].
  • 7Matsumoto K, Tanaka H, Yamana S, Kaneko A, Tsuji T, Ryo K, Sekiguchi K, Kawakami F, Kawai H, Hirata K. Successful steroid therapy for heart failure due to myocarditis associated with primary biliary cirrhosis. Can J Cardiol 2012; 28:515.e3-515.e6 [PMID: 22366508 DOI: 10.1016/ j.cjca.2011.12.010].
  • 8Lindor KD, Gershwin ME, Poupon R, Kaplan M, Bergasa NV, Heathcote EJ. Primary biliary cirrho- sis. Hepatology 2009; 50:291-308 [PMID: 19554543 DOI: 10.1002/hep.22906].
  • 9European Association for the Study of the Liver. EASL Clinical Practice Guidelines: manage-ment of cholestatic liver diseases. J Hepatol 2009; 51:237-267 [PMID: 19501929 DOI: 10.1016/ j.jhep.2009.04.009].
  • 10Bowlus CL, Gershwin ME. The diagnosis of primary biliary cirrhosis. Autoimmun Rev 2014; 13:441-444 [PMID: 24424173 DOI: 10.1016/ j.autrev.2014.01.041].

引证文献4

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部